United States Biotechnology & Medical Research

Olema Pharmaceuticals Inc (OLMA)

Olema Pharmaceuticals Inc. has seen no insider trading activity within the last three months. The most recent transactions occurred in July 2026, involving director Harmon Cyrus executing sales of company shares. Prior to this, various officers and former executives conducted multiple divestments throughout March 2026.
Ticker: OLMA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Olema Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.0
Harmon Cyrus Non-Executive Director
Transaction date
Sale
Price
455.24
Quantity 95,671 +21.6%
Value US$430,271
3.0
Harmon Cyrus Director Non-Executive Director
Transaction date
Proposed sale
Price
282.21
Quantity 87,175
Value US$1,063,817
3.0
Harmon Cyrus Non-Executive Director
Transaction date
Sale
Price
299.88
Quantity 26,230 +48.1%
Value US$1,569,813
3.0
Harmon Cyrus Director Non-Executive Director
Transaction date
Proposed sale
Price
11.58
Quantity 12,500
Value US$144,738
4.1
Kovacs Shane William Charles Former Officer Officer
Transaction date
Proposed sale
Price
16.61
Quantity 4,166
Value US$69,178
4.1
Kovacs Shane William Charles Former Officer Officer
Transaction date
Proposed sale
Price
16.08
Quantity 100,000
Value US$1,607,719
4.1
Kovacs Shane William Charles Former Officer Officer
Transaction date
Proposed sale
Price
15.94
Quantity 50,000
Value US$796,796
4.1
Kovacs Shane William Charles Former Officer Officer
Transaction date
Proposed sale
Price
17.00
Quantity 53,206
Value US$904,566
4.1
Kovacs Shane William Charles Former Officer Officer
Transaction date
Proposed sale
Price
13.45
Quantity 241,999
Value US$3,254,933
3.6
Mitchell Shawnte CHIEF LEGAL OFFICER Officer
Transaction date
Sale
Price
24.69
Quantity 233 -100.0%
Value US$5,753
3.6
Mitchell Shawnte CHIEF LEGAL OFFICER Officer
Transaction date
Sale
Price
24.25
Quantity 24,767 -99.1%
Value US$600,600
4.1
Kovacs Shane William Charles Former Officer Officer
Transaction date
Proposed sale
Price
24.43
Quantity 20,000
Value US$488,654
3.6
Mitchell Shawnte Officer Officer
Transaction date
Proposed sale
Price
23.94
Quantity 25,000
Value US$598,500
3.6
Mitchell Shawnte CHIEF LEGAL OFFICER Officer
Transaction date
Sale
Price
23.01
Quantity 15,000 -100.0%
Value US$345,150
3.6
Mitchell Shawnte Officer Officer
Transaction date
Proposed sale
Price
23.01
Quantity 15,000
Value US$345,153
4.1
Kovacs Shane William Charles Former Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 6,521
Value US$163,026
4.1
Kovacs Shane William Charles Former Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 20,000
Value US$500,002
4.1
Kovacs Shane William Charles Former Officer Officer
Transaction date
Proposed sale
Price
24.30
Quantity 10,000
Value US$243,000
4.1
Kovacs Shane William Charles Former Officer Officer
Transaction date
Proposed sale
Price
24.00
Quantity 20,000
Value US$480,007
4.1
Kovacs Shane William Charles Former Officer Officer
Transaction date
Proposed sale
Price
23.85
Quantity 10,000
Value US$238,498
3.0
Harmon Cyrus Non-Executive Director
Transaction date
Sale
Price
26.88
Quantity 10,000 -1.4%
Value US$268,800
3.0
Harmon Cyrus Director Non-Executive Director
Transaction date
Proposed sale
Price
26.88
Quantity 10,000
Value US$268,763
4.1
Kovacs Shane William Charles Officer Officer
Transaction date
Proposed sale
Price
28.73
Quantity 100,000
Value US$2,873,215
4.1
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Officer
Transaction date
Sale
Price
28.73
Quantity 100,000 -41.7%
Value US$2,873,000
3.0
Harmon Cyrus Non-Executive Director
Transaction date
Sale
Price
29.12
Quantity 3,489 -0.5%
Value US$101,600
3.0
Harmon Cyrus Director Non-Executive Director
Transaction date
Proposed sale
Price
29.12
Quantity 3,489
Value US$101,603
4.1
Myles David C. Officer Officer
Transaction date
Proposed sale
Price
28.87
Quantity 50,000
Value US$1,443,631
4.1
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Officer
Transaction date
Sale
Price
28.99
Quantity 35,003 -6.1%
Value US$1,014,737
4.1
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Officer
Transaction date
Sale
Price
28.60
Quantity 14,997 -2.5%
Value US$428,914
4.1
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Officer
Transaction date
Sale
Price
28.01
Quantity 3,822 -1.6%
Value US$107,054
4.1
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Officer
Transaction date
Sale
Price
28.49
Quantity 200 -0.0%
Value US$5,698
4.1
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Officer
Transaction date
Sale
Price
27.60
Quantity 49,800 -8.4%
Value US$1,374,480
4.1
Kovacs Shane William Charles Officer Officer
Transaction date
Proposed sale
Price
28.01
Quantity 3,822
Value US$107,069
4.1
Myles David C. Officer Officer
Transaction date
Proposed sale
Price
27.60
Quantity 50,000
Value US$1,380,113
4.1
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Officer
Transaction date
Sale
Price
28.34
Quantity 10,000 -6.5%
Value US$283,400
4.1
Myles David C. Officer Officer
Transaction date
Proposed sale
Price
28.34
Quantity 10,000
Value US$283,363
4.0
Zojwalla Naseem Officer Officer
Transaction date
Proposed sale
Price
27.66
Quantity 99,509
Value US$2,752,165
4.0
Zojwalla Naseem Chief Medical Officer Officer
Transaction date
Sale
Price
27.66
Quantity 99,509 -95.7%
Value US$2,752,419
3.0
Harmon Cyrus Non-Executive Director
Transaction date
Sale
Price
28.53
Quantity 2,881 -0.4%
Value US$82,195
4.0
Zojwalla Naseem Chief Medical Officer Officer
Transaction date
Sale
Price
28.04
Quantity 100,000 -64.9%
Value US$2,804,000
3.0
Harmon Cyrus Officer Officer
Transaction date
Proposed sale
Price
28.53
Quantity 2,881
Value US$82,182
4.0
Zojwalla Naseem Officer Officer
Transaction date
Proposed sale
Price
28.04
Quantity 100,000
Value US$2,804,039
4.1
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Officer
Transaction date
Sale
Price
31.39
Quantity 6,046 -1.1%
Value US$189,784
4.1
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Officer
Transaction date
Sale
Price
30.40
Quantity 43,729 -7.3%
Value US$1,329,362
4.1
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Officer
Transaction date
Planned sale
Price
28.08
Quantity 1,225 -0.2%
Value US$34,398
4.0
Zojwalla Naseem Chief Medical Officer Officer
Transaction date
Sale
Price
28.93
Quantity 12,921 -11.1%
Value US$373,805
4.0
Zojwalla Naseem Chief Medical Officer Officer
Transaction date
Sale
Price
28.03
Quantity 57,079 -32.8%
Value US$1,599,924
3.9
CLARK IAN T Non-Executive Director
Transaction date
Sale
Price
30.48
Quantity 41,840 -100.0%
Value US$1,275,283
3.9
CLARK IAN T Non-Executive Director
Transaction date
Sale
Price
29.71
Quantity 193,056 -82.2%
Value US$5,735,694
3.9
CLARK IAN T Non-Executive Director
Transaction date
Sale
Price
28.83
Quantity 29,904 -11.3%
Value US$862,132
4.1
Myles David C. Officer Officer
Transaction date
Proposed sale
Price
30.46
Quantity 51,000
Value US$1,553,447
4.0
Zojwalla Naseem Officer Officer
Transaction date
Proposed sale
Price
28.19
Quantity 70,000
Value US$1,973,561
3.9
CLARK IAN T Director Non-Executive Director
Transaction date
Proposed sale
Price
29.73
Quantity 264,800
Value US$7,873,502
3.0
Harmon Cyrus Director Non-Executive Director
Transaction date
Proposed sale
Price
8.33
Quantity 13,086
Value US$108,978
3.0
Harmon Cyrus Non-Executive Director
Transaction date
Sale
Price
8.32
Quantity 3,086 -2.6%
Value US$25,676
3.0
Harmon Cyrus Non-Executive Director
Transaction date
Sale
Price
8.33
Quantity 10,000 -1.3%
Value US$83,300
3.0
Harmon Cyrus Non-Executive Director
Transaction date
Sale
Price
8.08
Quantity 1,914 -1.6%
Value US$15,465
3.0
Harmon Cyrus Non-Executive Director
Transaction date
Sale
Price
8.04
Quantity 10,000 -1.3%
Value US$80,400
3.0
Harmon Cyrus Director Non-Executive Director
Transaction date
Proposed sale
Price
8.04
Quantity 11,914
Value US$95,827
3.0
Graham G. Walmsley Non-Executive Director
Transaction date
Sale
Price
6.75
Quantity 700,761 -100.0%
Value US$4,730,137
Logos Opportunities Fund I LP Affiliate
Transaction date
Proposed sale
Price
6.75
Quantity 700,761
Value US$4,730,137
3.0
Harmon Cyrus Director Non-Executive Director
Transaction date
Proposed sale
Price
8.68
Quantity 8,137
Value US$70,635
4.1
Myles David C. Officer Officer
Transaction date
Proposed sale
Price
8.68
Quantity 13,614
Value US$118,180
4.0
Zojwalla Naseem Officer Officer
Transaction date
Proposed sale
Price
8.68
Quantity 14,522
Value US$126,062
3.8
Bohen Sean Officer; Director Executive Director
Transaction date
Proposed sale
Price
8.68
Quantity 57,174
Value US$496,322
3.0
Harmon Cyrus Non-Executive Director
Transaction date
Sale
Price
9.39
Quantity 179 -0.0%
Value US$1,681
3.0
Harmon Cyrus Non-Executive Director
Transaction date
Sale
Price
8.66
Quantity 7,958 -1.0%
Value US$68,916
4.1
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Officer
Transaction date
Sale
Price
8.66
Quantity 17,950 -3.2%
Value US$155,447
4.1
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Officer
Transaction date
Sale
Price
9.39
Quantity 300 -0.1%
Value US$2,817
4.1
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Officer
Transaction date
Sale
Price
8.66
Quantity 13,314 -2.2%
Value US$115,299
3.8
Bohen Sean PRESIDENT AND CEO Executive Director
Transaction date
Sale
Price
9.39
Quantity 1,267 -0.5%
Value US$11,897
3.8
Bohen Sean PRESIDENT AND CEO Executive Director
Transaction date
Sale
Price
8.66
Quantity 55,907 -18.7%
Value US$484,155
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-27 2026-07-24 S Sale
3.0
Harmon Cyrus
Non-Executive Director
95,671 +21.6%
455.24
US$430,271 		95,671 +21.6% 455.24 US$430,271
2026-07-24 2026-07-24 PrS Proposed sale
3.0
Harmon Cyrus

Director

Non-Executive Director
87,175
282.21
US$1,063,817 		87,175 282.21 US$1,063,817
2026-07-27 2026-07-23 S Sale
3.0
Harmon Cyrus
Non-Executive Director
26,230 +48.1%
299.88
US$1,569,813 		26,230 +48.1% 299.88 US$1,569,813
2026-07-23 2026-07-23 PrS Proposed sale
3.0
Harmon Cyrus

Director

Non-Executive Director
12,500
11.58
US$144,738 		12,500 11.58 US$144,738
2026-03-16 2026-03-16 PrS Proposed sale
4.1
Kovacs Shane William Charles

Former Officer

Officer
4,166
16.61
US$69,178 		4,166 16.61 US$69,178
2026-03-16 2026-03-16 PrS Proposed sale
4.1
Kovacs Shane William Charles

Former Officer

Officer
100,000
16.08
US$1,607,719 		100,000 16.08 US$1,607,719
2026-03-11 2026-03-11 PrS Proposed sale
4.1
Kovacs Shane William Charles

Former Officer

Officer
50,000
15.94
US$796,796 		50,000 15.94 US$796,796
2026-03-10 2026-03-10 PrS Proposed sale
4.1
Kovacs Shane William Charles

Former Officer

Officer
53,206
17.00
US$904,566 		53,206 17.00 US$904,566
2026-03-09 2026-03-09 PrS Proposed sale
4.1
Kovacs Shane William Charles

Former Officer

Officer
241,999
13.45
US$3,254,933 		241,999 13.45 US$3,254,933
2026-03-05 2026-03-04 S Sale
3.6
Mitchell Shawnte

CHIEF LEGAL OFFICER

Officer
233 -100.0%
24.69
US$5,753 		233 -100.0% 24.69 US$5,753
2026-03-05 2026-03-04 S Sale
3.6
Mitchell Shawnte

CHIEF LEGAL OFFICER

Officer
24,767 -99.1%
24.25
US$600,600 		24,767 -99.1% 24.25 US$600,600
2026-03-04 2026-03-04 PrS Proposed sale
4.1
Kovacs Shane William Charles

Former Officer

Officer
20,000
24.43
US$488,654 		20,000 24.43 US$488,654
2026-03-04 2026-03-04 PrS Proposed sale
3.6
Mitchell Shawnte

Officer

Officer
25,000
23.94
US$598,500 		25,000 23.94 US$598,500
2026-03-05 2026-03-03 S Sale
3.6
Mitchell Shawnte

CHIEF LEGAL OFFICER

Officer
15,000 -100.0%
23.01
US$345,150 		15,000 -100.0% 23.01 US$345,150
2026-03-03 2026-03-03 PrS Proposed sale
3.6
Mitchell Shawnte

Officer

Officer
15,000
23.01
US$345,153 		15,000 23.01 US$345,153
2026-02-27 2026-02-27 PrS Proposed sale
4.1
Kovacs Shane William Charles

Former Officer

Officer
6,521
25.00
US$163,026 		6,521 25.00 US$163,026
2026-02-24 2026-02-24 PrS Proposed sale
4.1
Kovacs Shane William Charles

Former Officer

Officer
20,000
25.00
US$500,002 		20,000 25.00 US$500,002
2026-02-23 2026-02-23 PrS Proposed sale
4.1
Kovacs Shane William Charles

Former Officer

Officer
10,000
24.30
US$243,000 		10,000 24.30 US$243,000
2026-02-23 2026-02-23 PrS Proposed sale
4.1
Kovacs Shane William Charles

Former Officer

Officer
20,000
24.00
US$480,007 		20,000 24.00 US$480,007
2026-02-12 2026-02-12 PrS Proposed sale
4.1
Kovacs Shane William Charles

Former Officer

Officer
10,000
23.85
US$238,498 		10,000 23.85 US$238,498
2026-01-21 2026-01-20 S Sale
3.0
Harmon Cyrus
Non-Executive Director
10,000 -1.4%
26.88
US$268,800 		10,000 -1.4% 26.88 US$268,800
2026-01-20 2026-01-20 PrS Proposed sale
3.0
Harmon Cyrus

Director

Non-Executive Director
10,000
26.88
US$268,763 		10,000 26.88 US$268,763
2026-01-15 2026-01-15 PrS Proposed sale
4.1
Kovacs Shane William Charles

Officer

Officer
100,000
28.73
US$2,873,215 		100,000 28.73 US$2,873,215
2026-01-15 2026-01-15 S Sale
4.1
Kovacs Shane William Charles

CH. OPERATING & FINANCIAL OFF.

Officer
100,000 -41.7%
28.73
US$2,873,000 		100,000 -41.7% 28.73 US$2,873,000
2026-01-16 2026-01-14 S Sale
3.0
Harmon Cyrus
Non-Executive Director
3,489 -0.5%
29.12
US$101,600 		3,489 -0.5% 29.12 US$101,600
2026-01-14 2026-01-14 PrS Proposed sale
3.0
Harmon Cyrus

Director

Non-Executive Director
3,489
29.12
US$101,603 		3,489 29.12 US$101,603
2026-01-14 2026-01-14 PrS Proposed sale
4.1
Myles David C.

Officer

Officer
50,000
28.87
US$1,443,631 		50,000 28.87 US$1,443,631
2026-01-14 2026-01-14 S Sale
4.1
Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Officer
35,003 -6.1%
28.99
US$1,014,737 		35,003 -6.1% 28.99 US$1,014,737
2026-01-14 2026-01-14 S Sale
4.1
Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Officer
14,997 -2.5%
28.60
US$428,914 		14,997 -2.5% 28.60 US$428,914
2026-01-15 2026-01-13 S Sale
4.1
Kovacs Shane William Charles

CH. OPERATING & FINANCIAL OFF.

Officer
3,822 -1.6%
28.01
US$107,054 		3,822 -1.6% 28.01 US$107,054
2026-01-14 2026-01-13 S Sale
4.1
Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Officer
200 -0.0%
28.49
US$5,698 		200 -0.0% 28.49 US$5,698
2026-01-14 2026-01-13 S Sale
4.1
Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Officer
49,800 -8.4%
27.60
US$1,374,480 		49,800 -8.4% 27.60 US$1,374,480
2026-01-13 2026-01-13 PrS Proposed sale
4.1
Kovacs Shane William Charles

Officer

Officer
3,822
28.01
US$107,069 		3,822 28.01 US$107,069
2026-01-13 2026-01-13 PrS Proposed sale
4.1
Myles David C.

Officer

Officer
50,000
27.60
US$1,380,113 		50,000 27.60 US$1,380,113
2026-01-14 2026-01-12 S Sale
4.1
Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Officer
10,000 -6.5%
28.34
US$283,400 		10,000 -6.5% 28.34 US$283,400
2026-01-12 2026-01-12 PrS Proposed sale
4.1
Myles David C.

Officer

Officer
10,000
28.34
US$283,363 		10,000 28.34 US$283,363
2025-12-23 2025-12-23 PrS Proposed sale
4.0
Zojwalla Naseem

Officer

Officer
99,509
27.66
US$2,752,165 		99,509 27.66 US$2,752,165
2025-12-23 2025-12-23 S Sale
4.0
Zojwalla Naseem

Chief Medical Officer

Officer
99,509 -95.7%
27.66
US$2,752,419 		99,509 -95.7% 27.66 US$2,752,419
2025-12-29 2025-12-22 S Sale
3.0
Harmon Cyrus
Non-Executive Director
2,881 -0.4%
28.53
US$82,195 		2,881 -0.4% 28.53 US$82,195
2025-12-23 2025-12-22 S Sale
4.0
Zojwalla Naseem

Chief Medical Officer

Officer
100,000 -64.9%
28.04
US$2,804,000 		100,000 -64.9% 28.04 US$2,804,000
2025-12-22 2025-12-22 PrS Proposed sale
3.0
Harmon Cyrus

Officer

Officer
2,881
28.53
US$82,182 		2,881 28.53 US$82,182
2025-12-22 2025-12-22 PrS Proposed sale
4.0
Zojwalla Naseem

Officer

Officer
100,000
28.04
US$2,804,039 		100,000 28.04 US$2,804,039
2025-12-23 2025-12-19 S Sale
4.1
Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Officer
6,046 -1.1%
31.39
US$189,784 		6,046 -1.1% 31.39 US$189,784
2025-12-23 2025-12-19 S Sale
4.1
Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Officer
43,729 -7.3%
30.40
US$1,329,362 		43,729 -7.3% 30.40 US$1,329,362
2025-12-23 2025-12-19 PlS Planned sale
4.1
Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Officer
1,225 -0.2%
28.08
US$34,398 		1,225 -0.2% 28.08 US$34,398
2025-12-23 2025-12-19 S Sale
4.0
Zojwalla Naseem

Chief Medical Officer

Officer
12,921 -11.1%
28.93
US$373,805 		12,921 -11.1% 28.93 US$373,805
2025-12-23 2025-12-19 S Sale
4.0
Zojwalla Naseem

Chief Medical Officer

Officer
57,079 -32.8%
28.03
US$1,599,924 		57,079 -32.8% 28.03 US$1,599,924
2025-12-23 2025-12-19 S Sale
3.9
CLARK IAN T
Non-Executive Director
41,840 -100.0%
30.48
US$1,275,283 		41,840 -100.0% 30.48 US$1,275,283
2025-12-23 2025-12-19 S Sale
3.9
CLARK IAN T
Non-Executive Director
193,056 -82.2%
29.71
US$5,735,694 		193,056 -82.2% 29.71 US$5,735,694
2025-12-23 2025-12-19 S Sale
3.9
CLARK IAN T
Non-Executive Director
29,904 -11.3%
28.83
US$862,132 		29,904 -11.3% 28.83 US$862,132
2025-12-19 2025-12-19 PrS Proposed sale
4.1
Myles David C.

Officer

Officer
51,000
30.46
US$1,553,447 		51,000 30.46 US$1,553,447
2025-12-19 2025-12-19 PrS Proposed sale
4.0
Zojwalla Naseem

Officer

Officer
70,000
28.19
US$1,973,561 		70,000 28.19 US$1,973,561
2025-12-19 2025-12-19 PrS Proposed sale
3.9
CLARK IAN T

Director

Non-Executive Director
264,800
29.73
US$7,873,502 		264,800 29.73 US$7,873,502
2025-09-18 2025-09-18 PrS Proposed sale
3.0
Harmon Cyrus

Director

Non-Executive Director
13,086
8.33
US$108,978 		13,086 8.33 US$108,978
2025-09-18 2025-09-18 S Sale
3.0
Harmon Cyrus
Non-Executive Director
3,086 -2.6%
8.32
US$25,676 		3,086 -2.6% 8.32 US$25,676
2025-09-18 2025-09-18 S Sale
3.0
Harmon Cyrus
Non-Executive Director
10,000 -1.3%
8.33
US$83,300 		10,000 -1.3% 8.33 US$83,300
2025-09-18 2025-09-16 S Sale
3.0
Harmon Cyrus
Non-Executive Director
1,914 -1.6%
8.08
US$15,465 		1,914 -1.6% 8.08 US$15,465
2025-09-18 2025-09-16 S Sale
3.0
Harmon Cyrus
Non-Executive Director
10,000 -1.3%
8.04
US$80,400 		10,000 -1.3% 8.04 US$80,400
2025-09-16 2025-09-16 PrS Proposed sale
3.0
Harmon Cyrus

Director

Non-Executive Director
11,914
8.04
US$95,827 		11,914 8.04 US$95,827
2025-01-13 2025-01-08 B Purchase
2.8
Bain Capital Life Sciences Investors, LLC
Large shareholder
300,000 +4.0%
5.76
US$1,727,370 		300,000 +4.0% 5.76 US$1,727,370
2024-12-17 2024-12-17 S Sale
3.0
Graham G. Walmsley
Non-Executive Director
700,761 -100.0%
6.75
US$4,730,137 		700,761 -100.0% 6.75 US$4,730,137
2024-12-13 2024-12-13 PrS Proposed sale
Logos Opportunities Fund I LP

Affiliate
700,761
6.75
US$4,730,137 		700,761 6.75 US$4,730,137
2024-12-11 2024-12-11 PrS Proposed sale
3.0
Harmon Cyrus

Director

Non-Executive Director
8,137
8.68
US$70,635 		8,137 8.68 US$70,635
2024-12-11 2024-12-11 PrS Proposed sale
4.1
Kovacs Shane William Charles

Officer

Officer
18,356
8.68
US$159,345 		18,356 8.68 US$159,345
2024-12-11 2024-12-11 PrS Proposed sale
4.1
Myles David C.

Officer

Officer
13,614
8.68
US$118,180 		13,614 8.68 US$118,180
2024-12-11 2024-12-11 PrS Proposed sale
4.0
Zojwalla Naseem

Officer

Officer
14,522
8.68
US$126,062 		14,522 8.68 US$126,062
2024-12-11 2024-12-11 PrS Proposed sale
3.8
Bohen Sean

Officer; Director

Executive Director
57,174
8.68
US$496,322 		57,174 8.68 US$496,322
2024-12-11 2024-12-11 S Sale
3.0
Harmon Cyrus
Non-Executive Director
179 -0.0%
9.39
US$1,681 		179 -0.0% 9.39 US$1,681
2024-12-11 2024-12-11 S Sale
3.0
Harmon Cyrus
Non-Executive Director
7,958 -1.0%
8.66
US$68,916 		7,958 -1.0% 8.66 US$68,916
2024-12-11 2024-12-11 S Sale
4.1
Kovacs Shane William Charles

CH. OPERATING & FINANCIAL OFF.

Officer
406 -0.1%
9.39
US$3,812 		406 -0.1% 9.39 US$3,812
2024-12-11 2024-12-11 S Sale
4.1
Kovacs Shane William Charles

CH. OPERATING & FINANCIAL OFF.

Officer
17,950 -3.2%
8.66
US$155,447 		17,950 -3.2% 8.66 US$155,447
2024-12-11 2024-12-11 S Sale
4.1
Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Officer
300 -0.1%
9.39
US$2,817 		300 -0.1% 9.39 US$2,817
2024-12-11 2024-12-11 S Sale
4.1
Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

Officer
13,314 -2.2%
8.66
US$115,299 		13,314 -2.2% 8.66 US$115,299
2024-12-11 2024-12-11 S Sale
3.8
Bohen Sean

PRESIDENT AND CEO

Executive Director
1,267 -0.5%
9.39
US$11,897 		1,267 -0.5% 9.39 US$11,897
2024-12-11 2024-12-11 S Sale
3.8
Bohen Sean

PRESIDENT AND CEO

Executive Director
55,907 -18.7%
8.66
US$484,155 		55,907 -18.7% 8.66 US$484,155

See older Olema Pharmaceuticals Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Olema Pharmaceuticals Inc history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Olema Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America